News

Filter

1 to 9 of 69 results

Effective new cholesterol treatments will come at great cost to health care system, says CVS

Effective new cholesterol treatments will come at great cost to health care system, says CVS

18-02-2015

The new class of cholesterol drugs could provide successful treatment to millions of Americans, but the…

BiotechnologyCVS HealthGastro-intestinalsMarkets & MarketingPricingUSA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

12-02-2015

Anglo-Swedish pharma major AstraZeneca has agreed to pay the US government $7.9 million to settle allegations…

AstraZenecaCardio-vascularGastro-intestinalsLegalMarkets & MarketingNexiumPharmaceuticalPlendilPrilosecToprol XLUSA

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

11-02-2015

Swiss oncology specialist Helsinn has signed an exclusive agreement with Mundipharma to distribute and…

anamorelinGastro-intestinalsHelsinnLicensingMarkets & MarketingMundipharmaOncologyPharmaceutical

Tenfold growth by 2023 forecast for celiac disease drug market

Tenfold growth by 2023 forecast for celiac disease drug market

08-01-2015

The celiac disease treatment market value will expand more than tenfold from an estimated $49.6 million…

AbbVieEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

New drugs could drive celiac disease market to over $550 million by 2023, says analyst

New drugs could drive celiac disease market to over $550 million by 2023, says analyst

31-10-2014

The launches of Alba/Teva Pharmaceutical Industries’ larazotide acetate and Alvine/AbbVie’s latiglutenase…

AbbVieAlba TherapeuticAlvine PharmaceuticalsEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

Takelda combination tablets now available in Japan

Takelda combination tablets now available in Japan

13-06-2014

Japan’s largest drugmaker Takeda Pharmaceutical says that Takelda, a fixed-dose combination (FDC) of…

Gastro-intestinalsJapanMarkets & MarketingPharmaceuticalTakeda PharmaceuticalTakelda

1 to 9 of 69 results

COMPANY SPOTLIGHT

Menarini

Back to top